166 related articles for article (PubMed ID: 26472186)
1. Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.
Feng L; Xu Y; Zhang Y; Sun Z; Han J; Zhang C; Yang H; Shang D; Su F; Shi X; Li S; Li C; Li X
Oncotarget; 2015 Nov; 6(36):39151-64. PubMed ID: 26472186
[TBL] [Abstract][Full Text] [Related]
2. Computational Inferring of Risk Subpathways Mediated by Dysfunctional Non-coding RNAs.
Xu Y; Zhang Y; Li X
Adv Exp Med Biol; 2018; 1094():87-95. PubMed ID: 30191490
[TBL] [Abstract][Full Text] [Related]
3. Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies.
Shi X; Xu Y; Zhang C; Feng L; Sun Z; Han J; Su F; Zhang Y; Li C; Li X
Oncotarget; 2016 Oct; 7(43):69857-69870. PubMed ID: 27634882
[TBL] [Abstract][Full Text] [Related]
4. Dissection of human MiRNA regulatory influence to subpathway.
Li X; Jiang W; Li W; Lian B; Wang S; Liao M; Chen X; Wang Y; Lv Y; Wang S; Yang L
Brief Bioinform; 2012 Mar; 13(2):175-86. PubMed ID: 21908864
[TBL] [Abstract][Full Text] [Related]
5. Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Tian S; Tian J; Chen X; Li L; Liu Y; Wang Y; Sun Y; Zhang C; Lou G
Cell Physiol Biochem; 2017; 44(4):1325-1336. PubMed ID: 29183027
[TBL] [Abstract][Full Text] [Related]
6. Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways.
Feng C; Zhang J; Li X; Ai B; Han J; Wang Q; Wei T; Xu Y; Li M; Li S; Song C; Li C
Sci Rep; 2016 Sep; 6():33262. PubMed ID: 27625019
[TBL] [Abstract][Full Text] [Related]
7. Identifying miRNA-mediated signaling subpathways by integrating paired miRNA/mRNA expression data with pathway topology.
Vrahatis AG; Dimitrakopoulos GN; Tsakalidis AK; Bezerianos A
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3997-4000. PubMed ID: 26737170
[TBL] [Abstract][Full Text] [Related]
8. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
9. Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.
Li C; Han J; Yao Q; Zou C; Xu Y; Zhang C; Shang D; Zhou L; Zou C; Sun Z; Li J; Zhang Y; Yang H; Gao X; Li X
Nucleic Acids Res; 2013 May; 41(9):e101. PubMed ID: 23482392
[TBL] [Abstract][Full Text] [Related]
10. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Tian S; Mi W; Zhang M; Xing L; Zhang C
J Cell Mol Med; 2020 Feb; 24(4):2582-2592. PubMed ID: 31957240
[TBL] [Abstract][Full Text] [Related]
12. ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies.
Feng C; Song C; Ning Z; Ai B; Wang Q; Xu Y; Li M; Bai X; Zhao J; Liu Y; Li X; Zhang J; Li C
J Cell Mol Med; 2019 Feb; 23(2):967-984. PubMed ID: 30421585
[TBL] [Abstract][Full Text] [Related]
13. CHRONOS: a time-varying method for microRNA-mediated subpathway enrichment analysis.
Vrahatis AG; Dimitrakopoulou K; Balomenos P; Tsakalidis AK; Bezerianos A
Bioinformatics; 2016 Mar; 32(6):884-92. PubMed ID: 26568631
[TBL] [Abstract][Full Text] [Related]
14. The implications of relationships between human diseases and metabolic subpathways.
Li X; Li C; Shang D; Li J; Han J; Miao Y; Wang Y; Wang Q; Li W; Wu C; Zhang Y; Li X; Yao Q
PLoS One; 2011; 6(6):e21131. PubMed ID: 21695054
[TBL] [Abstract][Full Text] [Related]
15. Topologically inferring active miRNA-mediated subpathways toward precise cancer classification by directed random walk.
Ning Z; Feng C; Song C; Liu W; Shang D; Li M; Wang Q; Zhao J; Liu Y; Chen J; Yu X; Zhang J; Li C
Mol Oncol; 2019 Oct; 13(10):2211-2226. PubMed ID: 31408573
[TBL] [Abstract][Full Text] [Related]
16. The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure.
Li J; Li C; Han J; Zhang C; Shang D; Yao Q; Zhang Y; Xu Y; Liu W; Zhou M; Yang H; Su F; Li X
J Biomed Inform; 2014 Jun; 49():187-97. PubMed ID: 24561483
[TBL] [Abstract][Full Text] [Related]
17. Prioritization of rheumatoid arthritis risk subpathways based on global immune subpathway interaction network and random walk strategy.
Lv W; Wang Q; Chen H; Jiang Y; Zheng J; Shi M; Xu Y; Han J; Li C; Zhang R
Mol Biosyst; 2015 Nov; 11(11):2986-97. PubMed ID: 26289534
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data.
Liu S; Zheng B; Sheng Y; Kong Q; Jiang Y; Yang Y; Han X; Cheng L; Zhang Y; Han J
Front Genet; 2019; 10():441. PubMed ID: 31156704
[TBL] [Abstract][Full Text] [Related]
19. Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme.
Han X; Wang D; Zhao P; Liu C; Hao Y; Chang L; Zhao J; Zhao W; Mu L; Wang J; Li H; Kong Q; Han J
Front Oncol; 2020; 10():1549. PubMed ID: 33072547
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites.
Gong W; Xiao D; Ming G; Yin J; Zhou H; Liu Z
J Diabetes; 2014 Jul; 6(4):279-89. PubMed ID: 24606011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
